BIOGEN IDEC (IDP MU) stock market data APIs
€164.2473
0.02(0%)
as of March 31, 2026
Try our APIs with
free plan!
BIOGEN IDEC Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for IDP.MU.
Prev. Close
164.2473
Open
164.4261
High
164.6787
Low
163.9222
52 wk Range
99.02-169.95
Market Cap
30 257 M
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get BIOGEN IDEC data using free add-ons & libraries
Get BIOGEN IDEC Fundamental Data
BIOGEN IDEC Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
BIOGEN IDEC News
New
Apellis Pharmaceuticals (APLS) Hits 2-Year High on 140% Upside from Biogen Merger
Apellis Pharmaceuticals Inc. (NASDAQ:APLS) is one of the 10 Stocks Dominating Today’s Market Surge. Apellis Pharmaceuticals climbed to a new two-year high on Tuesday, as investors gobbled up shares...
The Year Is Off to the Strongest Start for Big Deals Ever
Companies are plowing ahead with corporate tie-ups and investments despite a war and slumping stocks. Continue Reading
Biogen (BIIB) Valuation Check After SPINRAZA Regimen Approval And Positive Lupus Data
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Biogen (BIIB) just cleared two important milestones, with...
Big Drug Companies Hunting for Deals Are Lowering Their Sights
About three quarters of pharmaceutical deals so far this year have been between $1 billion and $10 billion. Continue Reading
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
